According to our (Global Info Research) latest study, the global Pepsinogen I (PGI) Assay Kit market size was valued at US$ 77.98 million in 2025 and is forecast to a readjusted size of US$ 108 million by 2032 with a CAGR of 4.9% during review period.
The Pepsinogen I (PGI) Assay Kit is an in vitro diagnostic product designed for the quantitative determination of PGI levels in serum, plasma, or whole blood. Its primary function is to aid in the assessment of mucosal function in the gastric body and fundus, as well as the risk of atrophic gastritis.
The upstream supply chain comprises PGI antigens and antibodies, enzyme-linked or chemiluminescent substrates, magnetic microspheres, colloidal gold, calibrators, quality control materials, buffers, packaging materials, and components for detection instruments. The downstream market consists of hospital clinical laboratories, health examination centers, third-party testing laboratories, and primary care screening institutions.
Globally, the average unit price for PGI assay kits stands at $265 per kit, with an annual sales volume of approximately 286,000 kits. The industry's annual production capacity ranges from 500,000 to 600,000 kits, and the sector maintains a profit margin of approximately 40%.
The global market is projected to be driven by growing demand for early-stage gastric cancer screening, chronic gastritis management, and routine health check-ups. Consequently, PGI testing is expected to be increasingly utilized in conjunction with other biomarkers—such as Pepsinogen II (PGII), Gastrin-17, and Helicobacter pylori antibodies—to provide a more comprehensive diagnostic profile. Furthermore, the market share of chemiluminescence, fluorescence immunochromatography, and fully automated detection platforms is expected to rise; product development will trend toward enhanced sensitivity, standardization, rapid turnaround times, and increased accessibility within primary care settings. Additionally, the well-established screening infrastructure in high-incidence regions across Asia is anticipated to drive a sustained increase in clinical testing volumes.
This report is a detailed and comprehensive analysis for global Pepsinogen I (PGI) Assay Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pepsinogen I (PGI) Assay Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Pepsinogen I (PGI) Assay Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Pepsinogen I (PGI) Assay Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Pepsinogen I (PGI) Assay Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Boxes), and ASP (US$/Box), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pepsinogen I (PGI) Assay Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pepsinogen I (PGI) Assay Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BIOHIT HealthCare Oyj, Fujirebio Holdings, FUJIFILM Wako Pure Chemical Corporation, Eiken Chemical, Shima Laboratories, Shenzhen New Industries Biomedical Engineering, Autobio Diagnostics, ACON Biotech (Hangzhou), Tellgen Corporation, Hangzhou Biotest Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pepsinogen I (PGI) Assay Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Serum Detection Kit
Plasma Detection Kit
Whole Blood Detection Kit
Peripheral Blood Rapid Detection Kit
Market segment by Detection Method
Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescence Immunoassay (CLIA)
Colloidal Gold Method
Fluorescence Immunochromatography
Others
Market segment by Compatible Testing Platforms
Fully Automated Chemiluminescence Platform Kits
Biochemical Analyzer-Compatible Kits
Fluorescence Immunoassay Analyzer Kits
Manual ELISA Platform Kits
POCT (Point-of-Care Testing) Platform Kits
Market segment by Application
Hospital
Clinic
Drugstore
Major players covered
BIOHIT HealthCare Oyj
Fujirebio Holdings
FUJIFILM Wako Pure Chemical Corporation
Eiken Chemical
Shima Laboratories
Shenzhen New Industries Biomedical Engineering
Autobio Diagnostics
ACON Biotech (Hangzhou)
Tellgen Corporation
Hangzhou Biotest Biotech
Ebiotron Biotech
Vacure Biotechnology
Epitope Diagnostics
Thermo Fisher Scientific
RayBiotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pepsinogen I (PGI) Assay Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pepsinogen I (PGI) Assay Kit, with price, sales quantity, revenue, and global market share of Pepsinogen I (PGI) Assay Kit from 2021 to 2026.
Chapter 3, the Pepsinogen I (PGI) Assay Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pepsinogen I (PGI) Assay Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pepsinogen I (PGI) Assay Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pepsinogen I (PGI) Assay Kit.
Chapter 14 and 15, to describe Pepsinogen I (PGI) Assay Kit sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Pepsinogen I (PGI) Assay Kit. Industry analysis & Market Report on Pepsinogen I (PGI) Assay Kit is a syndicated market report, published as Global Pepsinogen I (PGI) Assay Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pepsinogen I (PGI) Assay Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.